Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA2A | P29274 | 18/20 | 0.65 |
| ▸ | ADORA3 | P0DMS8 | 7/20 | 0.65 |
| ▸ | ADORA2B | P29275 | 5/20 | 0.65 |
| ▸ | ADORA1 | P30542 | 5/20 | 0.65 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL238290 | 1.00 | ADORA2A (0.65) | ADORA2AADORA3ADORA2BADORA1 | |
| SCHEMBL6839105 | 0.92 | ADORA2A (0.55) | ADORA2AADORA3ADORA2BADORA1 | |
| SCHEMBL7103371 | 0.92 | ADORA3 (0.56) | ADORA2AADORA3ADORA2BADORA1 | |
| SCHEMBL6835048 | 0.92 | ADORA3 (0.56) | ADORA2AADORA3ADORA2BADORA1 | |
| SCHEMBL4371461 | 0.92 | ADORA2A (0.64) | ADORA2AADORA3ADORA2BADORA1 | |
| SCHEMBL4371473 | 0.92 | ADORA2A (0.64) | ADORA2AADORA3ADORA2BADORA1 | |
| SCHEMBL7104798 | 0.92 | ADORA2A (0.56) | ADORA2AADORA3ADORA2BADORA1 | |
| SCHEMBL7106559 | 0.91 | ADORA2A (0.55) | ADORA2AADORA3ADORA2BADORA1 | |
| SCHEMBL4563810 | 0.91 | ADORA2A (0.61) | ADORA2AADORA3ADORA2BADORA1 | |
| SCHEMBL5764372 | 0.90 | ADORA2A (0.62) | ADORA2AADORA3ADORA2BADORA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2013211-A2 | PURINE DERIVATIVES FOR USE AS ADENOSIN A2A RECEPTOR AGONISTS | Novartis AG (CH) | 2009-01-14 | — | — | EP | disclosed |
| WO-2007121920-A2 | PURINE DERIVATIVES FOR USE AS ADENOSIN A2A RECEPTOR AGONISTS | NOVARTIS AG (CH) | 2007-11-01 | — | — | WO | disclosed |